NewsStackNewsStack
Daily Brief: Which companies are hyping vs delivering: red flags, real signals and repeat offenders, free daily.

OXB

LSE:OXBLSE
7 announcements
Credibility Score49%
Oxford Biomedica — OXB confirms partnership with Aura Biosciences
OverhypedModerate hypeunclear

Oxford Biomedica secures a manufacturing deal for Aura’s Phase 3 cancer therapy.

17 Nov 2026, 07:00 UTC
▼
Manufacturing agreement with Plowshare Therapies
OverhypedModerate hypeunclear

This is a promotional partnership update with no disclosed financial impact or near-term upside.

16 Jul 2026, 06:07 UTC
▼
OXB Capital Markets Event
OverhypedModerate hypeunclear

Big promises for 2030, but little hard evidence or near-term delivery today.

2 Jun 2026, 06:12 UTC
▼
OXB to exhibit and present at the 30th Annual Meeting of the American Society of Cell and Gene Therapy (ASGCT)
OverhypedModerate hypeunclear

This is a technical showcase, not a business update—no new commercial wins or financials disclosed.

8 May 2026, 11:09 UTC
▼